Find a Commonwealth Resource
Lasmiditan
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Reyvow (lasmiditan) is a prescription oral tablet medication manufactured by Eli Lilly and Company, available in 50 mg and 100 mg strengths to treat acute migraines. The 200 mg strength has been discontinued. It is a controlled substance (CV schedule). This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Lasmiditan
Access the FDA dataset for Lasmiditan — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025